Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For:	Farrar M. Topical photodynamic therapy: the preferred choice for cutaneous field-cancerization? Br J Dermatol 2017;176:1116-1117. [DOI: 10.1111/bjd.15473] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]

Number

Cited by Other Article(s)

Wolf P. Ablative fractional laser-fortified daylight photodynamic therapy may be the patient's preferred choice for the treatment of field cancerization. Br J Dermatol 2019;180:697-698. [PMID: 30933335 DOI: 10.1111/bjd.17617] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]

Arimatsu A, Tomii K, Fujiwara H, Hasegawa G, Shigehara Y, Tachibana T. Photodynamic therapy can prevent recurrence of lymphomatoid papulosis. Photodiagnosis Photodyn Ther 2019;25:334-335. [DOI: 10.1016/j.pdpdt.2019.01.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2018] [Revised: 12/04/2018] [Accepted: 01/04/2019] [Indexed: 10/27/2022]

Ruiz-Villaverde R, Sáenz-Guirado S, Cuenca-Barrales C, Aguayo-Carreras P. Day light photodynamic therapy with BF-200 ALA: A case series. Dermatol Ther 2018;31:e12666. [DOI: 10.1111/dth.12666] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2018] [Revised: 06/10/2018] [Accepted: 06/22/2018] [Indexed: 11/30/2022]